ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
73,800
-7,100 (-8.78%)
At close: Dec 5, 2025
337.72%
Market Cap 1.14T
Revenue (ttm) 20.33B
Net Income (ttm) -7.33B
Shares Out 15.41M
EPS (ttm) -670.04
PE Ratio n/a
Forward PE 166.40
Dividend n/a
Ex-Dividend Date n/a
Volume 747,435
Average Volume 2,121,157
Open 81,100
Previous Close 80,900
Day's Range 73,800 - 81,500
52-Week Range 13,740 - 87,000
Beta n/a
RSI 63.98
Earnings Date Nov 14, 2025

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 74
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.